PL88837B1 - Enzymatic treatment of protein mixtures containing orgotein[us3806411a] - Google Patents
Enzymatic treatment of protein mixtures containing orgotein[us3806411a] Download PDFInfo
- Publication number
- PL88837B1 PL88837B1 PL1973164023A PL16402373A PL88837B1 PL 88837 B1 PL88837 B1 PL 88837B1 PL 1973164023 A PL1973164023 A PL 1973164023A PL 16402373 A PL16402373 A PL 16402373A PL 88837 B1 PL88837 B1 PL 88837B1
- Authority
- PL
- Poland
- Prior art keywords
- orgotein
- proteins
- mixture
- enzyme
- liver
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 82
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 82
- 108010070915 orgotein Proteins 0.000 title claims abstract description 64
- 229960004534 orgotein Drugs 0.000 title claims abstract description 64
- TUGDLVFMIQZYPA-UHFFFAOYSA-N tetracopper;tetrazinc Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2] TUGDLVFMIQZYPA-UHFFFAOYSA-N 0.000 title claims abstract description 64
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 230000002255 enzymatic effect Effects 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 54
- 210000004185 liver Anatomy 0.000 claims abstract description 27
- 102000035195 Peptidases Human genes 0.000 claims abstract description 19
- 108091005804 Peptidases Proteins 0.000 claims abstract description 19
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 6
- 239000007864 aqueous solution Substances 0.000 claims abstract description 4
- 229940088598 enzyme Drugs 0.000 claims description 29
- 102000004190 Enzymes Human genes 0.000 claims description 28
- 108090000790 Enzymes Proteins 0.000 claims description 28
- 108010019160 Pancreatin Proteins 0.000 claims description 19
- 229940055695 pancreatin Drugs 0.000 claims description 18
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000002955 isolation Methods 0.000 claims description 6
- 235000019833 protease Nutrition 0.000 claims description 6
- 238000005194 fractionation Methods 0.000 claims description 3
- 241000187392 Streptomyces griseus Species 0.000 claims description 2
- 230000002440 hepatic effect Effects 0.000 claims 1
- 238000000746 purification Methods 0.000 abstract description 6
- 235000015278 beef Nutrition 0.000 abstract 1
- 230000000593 degrading effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 21
- 239000007983 Tris buffer Substances 0.000 description 20
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 20
- 108010059712 Pronase Proteins 0.000 description 15
- 239000006228 supernatant Substances 0.000 description 13
- 239000000284 extract Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 8
- 235000021336 beef liver Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 150000001540 azides Chemical class 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 108090000787 Subtilisin Proteins 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 235000020004 porter Nutrition 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 2
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010063312 Metalloproteins Proteins 0.000 description 2
- 102000010750 Metalloproteins Human genes 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 239000001166 ammonium sulphate Substances 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- AXAVXPMQTGXXJZ-UHFFFAOYSA-N 2-aminoacetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(O)=O.OCC(N)(CO)CO AXAVXPMQTGXXJZ-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- CFYIUBWVKZQDOG-UHFFFAOYSA-N 4-[[2-[[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(NC(=O)CNC(=O)CNC(=O)CCC(=O)O)CC1=CC=CC=C1 CFYIUBWVKZQDOG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000000496 Carboxypeptidases A Human genes 0.000 description 1
- 108010080937 Carboxypeptidases A Proteins 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 108090001081 Dipeptidases Proteins 0.000 description 1
- 102000004860 Dipeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000002704 Leucyl aminopeptidase Human genes 0.000 description 1
- 108010004098 Leucyl aminopeptidase Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000223892 Tetrahymena Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 102100039662 Xaa-Pro dipeptidase Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- UNMLVGNWZDHBRA-UFAVQCRNSA-N alpha-L-Fucp-(1->3)-[alpha-D-Manp-(1->6)-[beta-D-Xylp-(1->2)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)]-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O[C@H]3[C@@H]([C@@H](O)[C@H](O)CO3)O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O UNMLVGNWZDHBRA-UFAVQCRNSA-N 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- -1 leucylopeptidase Proteins 0.000 description 1
- 229940040511 liver extract Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 108010066823 proline dipeptidase Proteins 0.000 description 1
- 108010017314 prolyl dipeptidase Proteins 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- WKQCYNCZDDJXEK-UHFFFAOYSA-N simalikalactone C Natural products C1C(C23C)OC(=O)CC3C(C)C(=O)C(O)C2C2(C)C1C(C)C=C(OC)C2=O WKQCYNCZDDJXEK-UHFFFAOYSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N25/00—Circuitry of solid-state image sensors [SSIS]; Control thereof
- H04N25/70—SSIS architectures; Circuits associated therewith
- H04N25/79—Arrangements of circuitry being divided between different or multiple substrates, chips or circuit boards, e.g. stacked image sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
- Y10S435/897—Streptomyces griseus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Signal Processing (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Multimedia (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00273278A US3806411A (en) | 1972-07-19 | 1972-07-19 | Enzymatic treatment of protein mixtures containing orgotein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL88837B1 true PL88837B1 (en) | 1976-09-30 |
Family
ID=23043280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1973164023A PL88837B1 (en) | 1972-07-19 | 1973-07-12 | Enzymatic treatment of protein mixtures containing orgotein[us3806411a] |
Country Status (23)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5811200B2 (ja) * | 1974-05-18 | 1983-03-01 | 鐘淵化学工業株式会社 | テイブンシリヨウ ノ コウボタンパクシツ オ セイゾウスルホウホウ |
| US3962039A (en) * | 1974-08-08 | 1976-06-08 | Center For Laboratory Medicine | Analytical procedure for thyroid hormones |
| FR2548214B1 (fr) * | 1983-06-14 | 1986-09-12 | Edinen Zentar Chim | Procede de traitement de la biomasse en vue de la separation des aminoacides et des lipides |
-
1972
- 1972-07-19 US US00273278A patent/US3806411A/en not_active Expired - Lifetime
- 1972-11-28 IL IL40956A patent/IL40956A/xx unknown
- 1972-11-30 HU HUDA302A patent/HU167256B/hu unknown
- 1972-12-04 AU AU49583/72A patent/AU464345B2/en not_active Expired
- 1972-12-04 ZA ZA728582A patent/ZA728582B/xx unknown
- 1972-12-15 CH CH1833172A patent/CH579915A5/xx not_active IP Right Cessation
- 1972-12-15 JP JP12669572A patent/JPS548756B2/ja not_active Expired
- 1972-12-21 AT AT10935/72A patent/AT320141B/de not_active IP Right Cessation
- 1972-12-28 DD DD168021*A patent/DD101902A5/xx unknown
- 1972-12-28 FI FI723678A patent/FI49170C/fi active
-
1973
- 1973-01-10 FR FR7300783A patent/FR2193084B1/fr not_active Expired
- 1973-01-23 NL NL7300935A patent/NL7300935A/xx not_active Application Discontinuation
- 1973-02-08 DE DE2306072A patent/DE2306072C2/de not_active Expired
- 1973-03-15 PH PH7314431A patent/PH12333A/en unknown
- 1973-04-17 GB GB1856973A patent/GB1423913A/en not_active Expired
- 1973-04-19 IE IE629/73A patent/IE38688B1/xx unknown
- 1973-05-22 SU SU1918551A patent/SU535912A3/ru active
- 1973-05-23 CA CA172,006A patent/CA1007587A/en not_active Expired
- 1973-07-12 PL PL1973164023A patent/PL88837B1/pl unknown
- 1973-07-17 CS CS7300005131A patent/CS182236B2/cs unknown
- 1973-07-17 IT IT51506/73A patent/IT1043862B/it active
- 1973-07-18 DK DK397573AA patent/DK133558B/da unknown
- 1973-07-18 NO NO2936/73A patent/NO137697C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Plummer Jr et al. | Human plasma carboxypeptidase N. Isolation and characterization. | |
| Ohmiya et al. | Purification and properties of a wall-bound endo-1, 4-β-glucanase from suspension-cultured poplar cells | |
| PL88837B1 (en) | Enzymatic treatment of protein mixtures containing orgotein[us3806411a] | |
| Evans et al. | Inactivation of cathepsin B by active site-directed disulfide exchange. Application in covalent affinity chromatography. | |
| Sopanen | Purification and partial characterization of a dipeptidase from barley | |
| JPH0586933B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE2363201B2 (de) | Verfahren zur Isolierung und Reinigung von Kallikrein aus biologischem Material | |
| US4252902A (en) | Process for purification of crude kallikrein | |
| CN111117989B (zh) | 一种从动物胰脏中提取三种酶的工艺方法 | |
| Sharma et al. | One step purification of peanut phospholipase D by precipitation with alginate | |
| US4035234A (en) | Process for the preparation of the kallikrein-trypsin inhibitor | |
| EP0019477A1 (en) | Process for isolating Cu, Zn-superoxide dismutase from aqueous solutions, and enzyme obtained | |
| Karlstam et al. | A simple purification method of squeezed krill for obtaining high levels of hydrolytic enzymes | |
| Pastore et al. | [23] Pteroyllysine-agarose in the purification of dihydrofolate reductase | |
| Ledeme et al. | Human liver L-leucine aminopeptidase: Evidence for two forms compared to pig liver enzyme | |
| Mathur et al. | Cobalt-ion chelate affinity chromatography for the purification of brain neutral alpha-D-mannosidase and its separation from acid alpha-D-mannosidase | |
| US4695550A (en) | ATP: polynucleotide adenylyltransferase enzyme and method of preparation thereof | |
| US4048014A (en) | Method for obtaining urokinase | |
| EP0060520B1 (en) | New carboxypeptidase a-gamma, process for preparing and pharmaceutical preparation containing same | |
| Shivaraj et al. | Natural plant enzyme inhibitors. Isolation of a trypsin/α‐amylase inhibitor and a chymotrypsin/trypsin inhibitor from ragi (Eleusine coracana) grains by affinity chromatography and study of their properties | |
| US4030977A (en) | Method for purification of physiologically active substance using enzyme-enzyme inhibitor system | |
| NO168218B (no) | Elektrisk hengeisolator | |
| US4261967A (en) | T-factor, CoA-SPC substantially free of proteolytic enzymes and its preparation | |
| US3630841A (en) | Purification of enzyme inhibitors | |
| Oshima et al. | Purification of Carboxypeptidase A Using Sepharose 4B-Bound 3-Phenylpropionate |